Terms: = Germ cell tumor AND LDH AND Diagnosis
208 results:
1. Characteristics of long-survivor metastatic melanoma after polychemotherapy and interferon: a retrospective study.
Py C; De Vito C; Tsantoulis P; Kaya G; Labidi-Galy SI; Dietrich PY
Swiss Med Wkly; 2023 Dec; 153():3504. PubMed ID: 38579317
[TBL] [Abstract] [Full Text] [Related]
2. Size selection of intrahepatic lesions for cryoablation contributes to abscopal effect and long-term survival in patients with liver metastatic melanoma receiving PD-1 blockade therapy.
Shen L; Tan H; Nie J; Jiang Y; Nuerhashi G; Qi H; Cao F; Wen C; Chen S; Zhang T; Zheng W; Liu P; Liu Y; Huang T; Li D; Zhang X; Fan W
Cancer Immunol Immunother; 2024 Mar; 73(4):68. PubMed ID: 38430269
[TBL] [Abstract] [Full Text] [Related]
3. A single-center retrospective analysis of prognoses in patients with melanoma brain metastases and effectiveness of treatment in Japan.
Wada S; Ogata D; Kashihara T; Okuma K; Eto H; Nakano E; Takahashi A; Namikawa K; Igaki H; Yamazaki N
Cancer Med; 2023 Dec; 12(24):21933-21943. PubMed ID: 38083908
[TBL] [Abstract] [Full Text] [Related]
4. Systemic therapy timing and use in patients with advanced melanoma at the end of life: A retrospective cohort study.
van Lith PEA; Schreuder K; Jalving M; Reyners AKL; Been LB; Rácz E; Fransen HP; Louwman MWJ
J Dermatol; 2024 Apr; 51(4):584-591. PubMed ID: 38078557
[TBL] [Abstract] [Full Text] [Related]
5. Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis.
Piulats JM; Watkins C; Costa-García M; Del Carpio L; Piperno-Neumann S; Rutkowski P; Hassel JC; Espinosa E; de la Cruz-Merino L; Ochsenreither S; Shoushtari AN; Orloff M; Salama AKS; Goodall HM; Baurain JF; Nathan P
Ann Oncol; 2024 Mar; 35(3):317-326. PubMed ID: 38048850
[TBL] [Abstract] [Full Text] [Related]
6. [Extragonadal germ cell tumor: A case report and review of the literature].
Li P; Wu D; Xu XF; Fu D; Jia RP; Ge JP
Zhonghua Nan Ke Xue; 2022 Nov; 28(11):1026-1030. PubMed ID: 37846120
[TBL] [Abstract] [Full Text] [Related]
7.
Huang X; Chen L; Sha T; Lin Y; Zeng R; Xu J; Chen S; Cai HH; Zhang J; Zhou H; Sun PH; Jiang X
ACS Nano; 2023 Oct; 17(20):20073-20086. PubMed ID: 37792448
[TBL] [Abstract] [Full Text] [Related]
8. Assessing the prognostic value of IMDC risk score for nivolumab-treated patients with renal cancer and malignant melanoma.
Beypınar I; Sözel Y; Önder AH
Cancer Biomark; 2023; 38(3):367-377. PubMed ID: 37718781
[TBL] [Abstract] [Full Text] [Related]
9. Development and validation of a nomogram based on common biochemical indicators for survival prediction of children with high-risk neuroblastoma: A valuable tool for resource-limited hospitals.
Wu R; Li X; Chen Z; Shao Q; Zhang X; Tang W; Hu B
BMC Pediatr; 2023 Aug; 23(1):426. PubMed ID: 37633889
[TBL] [Abstract] [Full Text] [Related]
10. Diagnostic value of CT and MRI combined with serum ldh, NSE, CEA, and MYCN in pediatric neuroblastoma.
Hao J; Sang J; Xu X; Bao A
World J Surg Oncol; 2023 Aug; 21(1):251. PubMed ID: 37592273
[TBL] [Abstract] [Full Text] [Related]
11. Outcomes in patients with
Aglietta M; Chiarion-Sileni V; Fava P; Guidoboni M; Depenni R; Minisini A; Consoli F; Ascierto PA; Rinaldi G; Banzi M; Marconcini R; Gueli R; Ferraresi V; Tucci M; Tonini G; Lo Re G; Guida M; Del Vecchio M; Marcon IG; Queirolo P
Tumori; 2023 Dec; 109(6):537-545. PubMed ID: 37417313
[TBL] [Abstract] [Full Text] [Related]
12. Absolute monocyte count has a diagnostic role in distinguishing tumor marker-negative TGCT from benign testicular tumor via CCL2 regulation.
Cao L; Chang Q; Sun J; Pang S; Fan Y; Liu J
Medicine (Baltimore); 2023 Jun; 102(25):e34114. PubMed ID: 37352031
[TBL] [Abstract] [Full Text] [Related]
13. Differences in glucose metabolic activity in liver metastasis separates two groups of metastatic uveal melanoma patients with different prognosis.
Del Carpio LP; Algarra MA; Sabaté-Llobera A; Rodriguez-Vida A; Rossi-Seoane S; Ruiz S; Leiva D; Ramos E; Lladò L; Lorenzo D; Gutierrez C; Cortes-Romera M; Caminal JM; Piulats JM
Cancer Med; 2023 Jul; 12(13):14062-14071. PubMed ID: 37211960
[TBL] [Abstract] [Full Text] [Related]
14. RNA Sequencing in Hypoxia-Adapted T98G Glioblastoma cells Provides Supportive Evidence for IRE1 as a Potential Therapeutic Target.
White BE; Liu Y; Hakonarson H; Buono RJ
Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107600
[TBL] [Abstract] [Full Text] [Related]
15. Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG.
Franklin C; Mohr P; Bluhm L; Meier F; Garzarolli M; Weichenthal M; Kähler K; Grimmelmann I; Gutzmer R; Utikal J; Terheyden P; Herbst R; Haferkamp S; Pfoehler C; Forschner A; Leiter U; Ziller F; Meiss F; Ulrich J; Kreuter A; Gebhardt C; Welzel J; Schilling B; Kaatz M; Scharfetter-Kochanek K; Dippel E; Nashan D; Sachse M; Weishaupt C; Löffler H; Gambichler T; Loquai C; Heinzerling L; Grabbe S; Debus D; Schley G; Hassel JC; Weyandt G; Trommer M; Lodde G; Placke JM; Zimmer L; Livingstone E; Becker JC; Horn S; Schadendorf D; Ugurel S
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37028819
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic Values of Primary tumor Textural Heterogeneity and Blood Biomarkers in High-risk Neuroblastoma.
Vural O; Aydos U; Okur A; Pinarli FG; Atay LÖ
J Pediatr Hematol Oncol; 2023 Oct; 45(7):383-391. PubMed ID: 37027243
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation of the M371-Test Under Real-life Conditions for diagnosis and Follow Up of Testicular germ cell tumors.
Pycha S; D'Elia C; Mian C; Schwienbacher C; Hanspeter E; Palermo M; Pycha A; Danuser H; Trenti E
Anticancer Res; 2023 Apr; 43(4):1649-1653. PubMed ID: 36974797
[TBL] [Abstract] [Full Text] [Related]
18. Εmerging Biomarkers in the diagnosis and Treatment of Testicular tumors.
Evmorfopoulos K; Vlachostergios PJ; Sountoulides P; Tzortzis V
Curr Cancer Drug Targets; 2023; 23(11):858-867. PubMed ID: 36967458
[TBL] [Abstract] [Full Text] [Related]
19. Association of image-defined risk factors with clinical features, tumor biology, and outcomes in neuroblastoma: a single-center retrospective study.
Yang DD; Liu C; Gao J; Hu QJ; Liang Y; Liu J
Eur J Pediatr; 2023 May; 182(5):2189-2196. PubMed ID: 36856889
[TBL] [Abstract] [Full Text] [Related]
20. Combined analysis of PHOX2B at two time points and its value for further risk stratification in high-risk neuroblastoma.
Yue Z; Gao C; Xing T; Zhao W; Duan C; Wang X; Jin M; Su Y
Pediatr Blood Cancer; 2023 May; 70(5):e30261. PubMed ID: 36815592
[TBL] [Abstract] [Full Text] [Related]
[Next]
